Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.

Wang J, Okkeri J, Pavic K, Wang Z, Kauko O, Halonen T, Sarek G, Ojala PM, Rao Z, Xu W, Westermarck J.

EMBO Rep. 2017 Mar;18(3):437-450. doi: 10.15252/embr.201642788. Epub 2017 Feb 7.

PMID:
28174209
2.

A Role for the Twins Protein Phosphatase (PP2A-B55) in the Maintenance of Drosophila Genome Integrity.

Merigliano C, Marzio A, Renda F, Somma MP, Gatti M, Vernì F.

Genetics. 2017 Mar;205(3):1151-1167. doi: 10.1534/genetics.116.192781. Epub 2016 Dec 30.

PMID:
28040742
3.

Protein Phosphatases Involved in Regulating Mitosis: Facts and Hypotheses.

Kim HS, Fernandes G, Lee CW.

Mol Cells. 2016 Sep;39(9):654-62. doi: 10.14348/molcells.2016.0214. Epub 2016 Sep 27. Review.

4.

New insights on the role of epigenetic alterations in hepatocellular carcinoma.

Frau M, Feo CF, Feo F, Pascale RM.

J Hepatocell Carcinoma. 2014 Jun 12;1:65-83. doi: 10.2147/JHC.S44506. eCollection 2014 Jun 12. Review.

5.

Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors.

Smith AM, Dun MD, Lee EM, Harrison C, Kahl R, Flanagan H, Panicker N, Mashkani B, Don AS, Morris J, Toop H, Lock RB, Powell JA, Thomas D, Guthridge MA, Moore A, Ashman LK, Skelding KA, Enjeti A, Verrills NM.

Oncotarget. 2016 Jul 26;7(30):47465-47478. doi: 10.18632/oncotarget.10167.

6.

Promotion of Cell Viability and Histone Gene Expression by the Acetyltransferase Gcn5 and the Protein Phosphatase PP2A in Saccharomyces cerevisiae.

Petty EL, Lafon A, Tomlinson SL, Mendelsohn BA, Pillus L.

Genetics. 2016 Aug;203(4):1693-707. doi: 10.1534/genetics.116.189506. Epub 2016 Jun 17.

PMID:
27317677
7.

Retroviral DNA Integration.

Lesbats P, Engelman AN, Cherepanov P.

Chem Rev. 2016 Oct 26;116(20):12730-12757. doi: 10.1021/acs.chemrev.6b00125. Epub 2016 May 20.

8.

Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia.

Arriazu E, Pippa R, Odero MD.

Front Oncol. 2016 Apr 6;6:78. doi: 10.3389/fonc.2016.00078. eCollection 2016 Apr 6. Review.

9.

HDAC1 controls CIP2A transcription in human colorectal cancer cells.

Balliu M, Cellai C, Lulli M, Laurenzana A, Torre E, Vannucchi AM, Paoletti F.

Oncotarget. 2016 May 3;7(18):25862-71. doi: 10.18632/oncotarget.8406.

10.

Regulation of Beclin 1 Protein Phosphorylation and Autophagy by Protein Phosphatase 2A (PP2A) and Death-associated Protein Kinase 3 (DAPK3).

Fujiwara N, Usui T, Ohama T, Sato K.

J Biol Chem. 2016 May 13;291(20):10858-66. doi: 10.1074/jbc.M115.704908. Epub 2016 Mar 18.

PMID:
26994142
11.

PP2A as a master regulator of the cell cycle.

Wlodarchak N, Xing Y.

Crit Rev Biochem Mol Biol. 2016 May-Jun;51(3):162-84. doi: 10.3109/10409238.2016.1143913. Epub 2016 Feb 24.

12.

PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.

Hein AL, Seshacharyulu P, Rachagani S, Sheinin YM, Ouellette MM, Ponnusamy MP, Mumby MC, Batra SK, Yan Y.

Cancer Res. 2016 Apr 15;76(8):2243-53. doi: 10.1158/0008-5472.CAN-15-2119. Epub 2016 Feb 18.

PMID:
26893480
13.

Norcantharidin inhibits renal interstitial fibrosis by downregulating PP2Ac expression.

Hou T, Xiao Z, Li Y, You YH, Li H, Liu YP, Xi YY, Li J, Duan SB, Liu H, Sun L, Peng YM, Liu FY.

Am J Transl Res. 2015 Nov 15;7(11):2199-211. eCollection 2015 Nov 15.

14.

IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis.

Asano Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, Tatebe S, Kitabayashi I, Tashiro F, Namiki H, Kondo T, Semba K, Aburatani H, Taya Y, Nakagama H, Ohki R.

Sci Rep. 2016 Jan 12;6:19174. doi: 10.1038/srep19174.

15.

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.

Shu S, Lin CY, He HH, Witwicki RM, Tabassum DP, Roberts JM, Janiszewska M, Huh SJ, Liang Y, Ryan J, Doherty E, Mohammed H, Guo H, Stover DG, Ekram MB, Peluffo G, Brown J, D'Santos C, Krop IE, Dillon D, McKeown M, Ott C, Qi J, Ni M, Rao PK, Duarte M, Wu SY, Chiang CM, Anders L, Young RA, Winer EP, Letai A, Barry WT, Carroll JS, Long HW, Brown M, Liu XS, Meyer CA, Bradner JE, Polyak K.

Nature. 2016 Jan 21;529(7586):413-7. doi: 10.1038/nature16508. Epub 2016 Jan 6.

16.

Protein Phosphatase Methyl-Esterase PME-1 Protects Protein Phosphatase 2A from Ubiquitin/Proteasome Degradation.

Yabe R, Miura A, Usui T, Mudrak I, Ogris E, Ohama T, Sato K.

PLoS One. 2015 Dec 17;10(12):e0145226. doi: 10.1371/journal.pone.0145226. eCollection 2015 Dec 17.

17.

B'-protein phosphatase 2A is a functional binding partner of delta-retroviral integrase.

Maertens GN.

Nucleic Acids Res. 2016 Jan 8;44(1):364-76. doi: 10.1093/nar/gkv1347. Epub 2015 Dec 10.

18.

Systematic study of cis-antisense miRNAs in animal species reveals miR-3661 to target PPP2CA in human cells.

Wang J, Li Z, Liu B, Chen G, Shao N, Ying X, Wang Y.

RNA. 2016 Jan;22(1):87-95. doi: 10.1261/rna.052894.115. Epub 2015 Nov 17.

19.

Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.

Hu X, Garcia C, Fazli L, Gleave M, Vitek MP, Jansen M, Christensen D, Mulholland DJ.

Sci Rep. 2015 Nov 13;5:15182. doi: 10.1038/srep15182.

20.

All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.

Sangodkar J, Farrington CC, McClinch K, Galsky MD, Kastrinsky DB, Narla G.

FEBS J. 2016 Mar;283(6):1004-24. doi: 10.1111/febs.13573. Epub 2015 Nov 14. Review.

Supplemental Content

Support Center